Financials
- Market Capitalization 1.95 B
- Employee 367
- Founded 2016
- CEO Marianne De Backer
- Website www.vir.bio
- Headquarter Delaware, United States
- FIGI BBG00H2QQ8T5
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-5.48
ratio cours/chiffre d'affaires
5.42
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1994 | AGIO Agios Pharmaceuticals, Inc. - Common Stock | 33.72 USD | +0.12% | -0.24% | +9.55% | -22.29% | 2.01 B USD | ||
| 2008 | STOK Stoke Therapeutics, Inc. - Common Stock | 30.88 USD | -1.03% | -7.18% | +7.90% | +56.04% | 1.99 B USD | ||
| 2027 | NBTX Nanobiotix S.A. - ADSs | 39.51 USD | -2.78% | -3.87% | +5.16% | +376.60% | 1.91 B USD | ||
| 2028 | MRVI Maravai LifeSciences Holdings, Inc. - Class A common stock | 7.36 USD | -3.66% | -15.79% | +11.52% | +207.95% | 1.91 B USD |